Sr One Capital Management as of Sept. 30, 2024
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 11 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 39.3 | $196M | 2.3M | 83.51 | |
| Zenas BioPharma Common Stock (ZBIO) | 16.7 | $83M | 4.9M | 16.92 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 11.7 | $58M | 4.0M | 14.50 | |
| CRISPR Therapeutics Common Shares (CRSP) | 9.9 | $49M | 1.0M | 46.98 | |
| Design Therapeutics Common Stock (DSGN) | 7.0 | $35M | 6.5M | 5.38 | |
| Mineralys Therapeutics Common Stock (MLYS) | 4.9 | $24M | 2.0M | 12.11 | |
| Alumis Common Stock (ALMS) | 4.2 | $21M | 2.0M | 10.68 | |
| Nkarta Common Stock (NKTX) | 3.0 | $15M | 3.3M | 4.52 | |
| Oruka Therapeutics Common Stock (ORKA) | 1.8 | $9.2M | 375k | 24.51 | |
| enGene Holdings Common Shares (ENGN) | 1.0 | $4.9M | 748k | 6.60 | |
| KALA Bio Common Stock (KALA) | 0.5 | $2.5M | 444k | 5.70 |
